News
Hosted on MSN4mon
Why semaglutide may reduce alcohol cravings, heavy drinking - MSNSemaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help people drink less alcohol. A study published in JAMA Psychiatry enrolled ...
Please use one of the following formats to cite this article in your essay, paper or report: APA. Bose, Priyom. (2025, February 13). Low-dose semaglutide reduces alcohol consumption and cravings ...
Simmons is the director of OSU’s Biomedical Imaging Center and lead investigator on the Semaglutide Therapy for Alcohol Reduction — Tulsa, or STAR-T, clinical trial.He also published one of ...
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name Ozempic — may help reduce not only alcohol cravings, but the amount of ...
Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder (AUD) reduce the amount they drink – pointing to yet another potential use ...
Semaglutide (the active ingredient in Ozempic and Wegovy) and similar GLP-1 drugs are far more effective at helping people lose weight than diet and exercise alone. But some scientists have also ...
There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more research is needed.
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy and used to treat coexisting conditions.
Semaglutide and related weight-loss medications, known as GLP-1 agonists, may slow biological ageing, reduce inflammation, improve cognitive function and gut health, and reduce alcohol use in people ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results